These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23253254)

  • 101. [Computed tomographic morphological evaluation of neoadjuvant chemotherapy. Effectiveness of the therapy for colorectal liver metastases].
    Folprecht G; Weitz J; Hoffmann RT
    Chirurg; 2014 Jan; 85(1):31-6. PubMed ID: 24366286
    [TBL] [Abstract][Full Text] [Related]  

  • 102. The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score.
    Yonekawa Y; Uehara K; Mizuno T; Aiba T; Ogura A; Mukai T; Yokoyama Y; Ebata T; Kodera Y; Nagino M
    Int J Clin Oncol; 2021 Jan; 26(1):126-134. PubMed ID: 33074351
    [TBL] [Abstract][Full Text] [Related]  

  • 103. [Treatment of colorectal and non-colorectal liver metastases: rationale for neoadjuvant therapeutic concepts].
    Gül-Klein S; Schmuck R; Modest DP; Pratschke J
    Chirurg; 2020 May; 91(5):396-404. PubMed ID: 32291472
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Disappearing colorectal liver metastases: Strategies for the management of patients achieving a radiographic complete response after systemic chemotherapy.
    Araujo RLC; Milani JM; Armentano DP; Moreira RB; Pinto GSF; de Castro LA; Lucchesi FR
    J Surg Oncol; 2020 Apr; 121(5):848-856. PubMed ID: 31773747
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone?
    Khan K; Wale A; Brown G; Chau I
    World J Gastroenterol; 2014 Sep; 20(35):12391-406. PubMed ID: 25253940
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Treatment of colorectal liver metastases.
    Geoghegan JG; Scheele J
    Br J Surg; 1999 Feb; 86(2):158-69. PubMed ID: 10100781
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Neoadjuvant chemotherapy response influences outcomes in non-colorectal, non-neuroendocrine liver metastases.
    Lucchese AM; Kalil AN; Ruiz A; Karam V; Ciacio O; Pittau G; Castaing D; Cherqui D; Sa Cunha A; Vibert E; Adam R
    Br J Surg; 2018 Nov; 105(12):1665-1670. PubMed ID: 29893476
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Treatment of liver metastases from colorectal cancer: what is the best approach today?
    Biasco G; Gallerani E
    Dig Liver Dis; 2001; 33(5):438-44. PubMed ID: 11529658
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Thinking Too Fast About Chemotherapy for Resectable Colorectal Cancer Liver Metastases?
    Pereira AAL; Dos Santos Fernandes G
    Clin Colorectal Cancer; 2022 Sep; 21(3):e187-e188. PubMed ID: 35680525
    [No Abstract]   [Full Text] [Related]  

  • 110. Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy?
    Ayez N; Lalmahomed ZS; van der Pool AE; Vergouwe Y; van Montfort K; de Jonge J; Eggermont AM; Ijzermans JN; Verhoef C
    Ann Surg Oncol; 2011 Oct; 18(10):2757-63. PubMed ID: 21638093
    [TBL] [Abstract][Full Text] [Related]  

  • 111. The role of peri-operative chemotherapy for resectable colorectal liver metastasis: what does the evidence support?
    Pawlik TM; Cosgrove D
    J Gastrointest Surg; 2011 Mar; 15(3):410-5. PubMed ID: 21253876
    [No Abstract]   [Full Text] [Related]  

  • 112. [Surgical treatment of liver metastases from colorectal cancer].
    Søreide JA; Eiriksson K; Sandvik O; Viste A; Horn A; Johnsen G; Grønbech JE
    Tidsskr Nor Laegeforen; 2008 Jan; 128(1):50-3. PubMed ID: 18183058
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs.
    Hao Z; Parasramka S; Chen Q; Jacob A; Huang B; Mullett T; Benson AB
    Oncologist; 2023 Jan; 28(1):48-58. PubMed ID: 36200844
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases.
    Kanikarla Marie P; Haymaker C; Parra ER; Kim YU; Lazcano R; Gite S; Lorenzini D; Wistuba II; Tidwell RSS; Song X; Foo WC; Maru DM; Chun YS; Futreal A; Kee B; Menter D; Solis L; Tzeng CW; Parseghian C; Raghav K; Morris V; Chang CC; Jenq R; Tam A; Bernatchez C; Kopetz S; Vauthey JN; Overman MJ
    Clin Cancer Res; 2021 Jun; 27(11):3039-3049. PubMed ID: 33811152
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Preoperative chemotherapy in upfront resectable colorectal liver metastases: New elements for an old dilemma?
    Bernardi L; Roesel R; Aghayan DL; Majno-Hurst PE; De Dosso S; Cristaudi A
    Cancer Treat Rev; 2024 Mar; 124():102696. PubMed ID: 38335813
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Pathological complete response after neoadjuvant chemotherapy for rectal cancer with synchronous multiple liver metastases: a report of an unusual case.
    Arata R; Itamoto T; Ikeda S; Nakahara H; Oshita A; Shinozaki K; Nishisaka T
    Surg Case Rep; 2016 Dec; 2(1):106. PubMed ID: 27686666
    [TBL] [Abstract][Full Text] [Related]  

  • 117. [An active approach to liver metastasis].
    Sustácek J; Malecek M; Krejs V
    Acta Medica (Hradec Kralove) Suppl; 1997; 40(2):93-5. PubMed ID: 10103149
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Beppu's Nomogram Score Is an Independent Prognostic Factor for Colorectal Liver Metastasis Receiving Perioperative Chemotherapy and/or Targeted Therapy.
    Higuchi A; Aoyama T; Kazama K; Murakawa M; Atsumi Y; Katayama Y; Numata K; Sawazaki S; Numata M; Sato S; Sugano N; Tamagawa H; Mushiake H; Oshima T; Yukawa N; Morinaga S; Rino Y; Masuda M; Shiozawa M
    In Vivo; 2019; 33(4):1301-1306. PubMed ID: 31280222
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Treatment dilemmas in patients with synchronous colorectal liver metastases.
    Ruers TJ; Hagendoorn J
    Recent Results Cancer Res; 2012; 196():37-49. PubMed ID: 23129365
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Clinical Outcomes of Neoadjuvant Chemotherapy in Colorectal Cancer Patients With Synchronous Resectable Liver Metastasis: A Propensity Score Matching Analysis.
    Park SH; Shin JK; Lee WY; Yun SH; Cho YB; Huh JW; Park YA; Heo JS; Choi GS; Kim ST; Park YS; Kim HC
    Ann Coloproctol; 2021 Aug; 37(4):244-252. PubMed ID: 34182620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.